Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Shortage reports
Actual shortage:
0 (0%)
Anticipated shortage:
1 (1%)
Avoided shortage:
8 (7%)
Resolved:
98 (92%)
107
Discontinuation Reports
To be discontinued:
1 (17%)
Discontinued:
5 (83%)
Reversed:
0 (0%)
6
0 (0%)
0 (0%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-21 | 144296 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-05 | 160516 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2022-05-13 | 2023-01-31 | 160519 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-15 | 217414 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2024-01-26 | 2024-02-24 | 217420 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2024-03-07 | 2024-03-14 | 221590 |
| VISIPAQUE 320 | 652MG | SOLUTION | Resolved | 2021-07-30 | 2021-08-21 | 143297 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| OMNIPAQUE 180 | 388MG | SOLUTION | Discontinued | 2023-01-31 | 2023-02-22 | 182757 |
| OMNIPAQUE 240 | 518MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-18 | 182760 |
| OMNISCAN | 287MG | SOLUTION | Discontinued | 2023-01-31 | 2023-03-25 | 182742 |
| SEHCAT | 370KBq | CAPSULE | To be discontinued | 2026-02-12 | 2026-02-12 | 277848 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 6 of 6